These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 14159475)
21. ACTIVATION OF RABBIT PLASMINOGEN BY STREPTOKINASE. CHATTOPADHYAY DP; CLIFFTON EE Am J Physiol; 1965 Jan; 208():190-7. PubMed ID: 14253148 [No Abstract] [Full Text] [Related]
22. PRACTICAL METHOD FOR THROMBOLYTIC THERAPY WITH STREPTOKINASE. MAINTENANCE OF NEARLY COMPLETE PLASMINOGEN DEPLETION ASSOCIATED WITH HIGH CIRCULATING ACTIVATOR ACTIVITY. VERSTRAETE M; AMERY A; VERMYLEN J; VERMYLEN C; DEVREKER R Br Med J; 1964 Mar; 1(5384):675-6. PubMed ID: 14096464 [No Abstract] [Full Text] [Related]
23. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY. HUME M J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458 [No Abstract] [Full Text] [Related]
24. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY]. KAPPERT A Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260 [No Abstract] [Full Text] [Related]
25. [Research on fibrinolysis: the fibrinolysis factors in Kline's plasminogen]. GIACOMAZZI G Haematol Lat; 1961; 4():339-70. PubMed ID: 13898267 [No Abstract] [Full Text] [Related]
26. [On practical execution of fibrinolysis therapy with enzyme preparations]. DEUTSCH E; FISCHER M; STACHER A Folia Haematol (Frankf); 1961 Oct; 6():310-7. PubMed ID: 13885851 [No Abstract] [Full Text] [Related]
27. THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM. JACOBSEN CD Scand J Clin Lab Invest; 1964; 16():372-82. PubMed ID: 14202017 [No Abstract] [Full Text] [Related]
28. THE EFFECT OF HEPARIN ON FIBRINOLYTIC ACTIVATORS AND PLASMIN. NILSSON IM; BIELAWIEC M; BJOERKMAN SE Scand J Haematol; 1964; 1():75-88. PubMed ID: 14175721 [No Abstract] [Full Text] [Related]
32. [PRESENT STATUS OF THROMBOLYTIC THERAPY]. VAIREL EG; ANTOINE G Sangre (Barc); 1964; 41():441-6. PubMed ID: 14248832 [No Abstract] [Full Text] [Related]
33. [Studies on the effect of urokinase on the fibrinolytic activity of the blood]. ANDREENKO GV; STRUKOVA SM Biokhimiia; 1962; 27():327-9. PubMed ID: 13861411 [No Abstract] [Full Text] [Related]
34. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW. LIEBERMAN J Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772 [TBL] [Abstract][Full Text] [Related]
35. FIBRINOLYTIC THERAPY IN MENINGITIS AND VENTRICULITIS. STEWART GT J Clin Pathol; 1964 May; 17(3):355-9. PubMed ID: 14159482 [No Abstract] [Full Text] [Related]
36. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE). JAMES DC; BROWSE NL Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065 [No Abstract] [Full Text] [Related]
37. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT. COON WW Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774 [No Abstract] [Full Text] [Related]
38. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN. BLATT WF; GRAY JL; JENSEN H Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118 [No Abstract] [Full Text] [Related]
39. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE. BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046 [No Abstract] [Full Text] [Related]
40. THE FIBRINOLYTIC SYSTEM IN BLOOD AFTER RETENTION OF A DEAD FETUS AND DURING NORMAL LABOR. BRAKMAN P; KING AE Am J Obstet Gynecol; 1965 May; 92():221-6. PubMed ID: 14281832 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]